AbbVie is a leading research-driven global biopharmaceutical company. The company produces drugs for several different therapeutic areas such as rheumatology, oncology, virology, neurology, etc.
AbbVie’s blockbuster drug, Humira is one of the best-selling drugs globally and accounts for nearly 60% of the company’s revenue. The drug is used to treat psoriasis and rheumatoid arthritis. Other key products include Lupron, Creon, Androgel, and Marinol. The company also has a robust late-stage pipeline across several therapeutic areas.
The company has a large distribution network consisting of AbbVie-owned distribution centers and warehouses from where AbbVie's products reach wholesalers, distributors, and government agencies worldwide. AbbVie operates through only one business segment - Pharmaceuticals.
Key Investment Data
- Ticker: nyse:ABBV
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Market Cap: 242.70B
- Market Cap Group: Mega Cap
- P/E: 10.51
- Dividend Yield: 4.30%
- Grade: B
- Dividend Aristocrat: YES
- Chowder Score: Members Only
- Revenue Growth: Members Only
- Dividend Growth: Members Only
- Dividend Growth Fit: 5/10
- Dividend Income Fit: 5/10
Competitors
The competitive landscape is important as they compete for the same business. Below is the list of competitors in the same industry. While not displayed, a number of metrics you can also use to evaluate your picks are the Chowder Score, the Relative Strength Index (RSI), the Graham Number, and the Piotroski F-Score.
| Ticker | Ticker | Company | Market Cap | P/E | Yield | Aristocrat | Graph | SectorID | IndustryID |
|---|---|---|---|---|---|---|---|---|---|
| LLY | NYSE:LLY | Lilly | 404.19 | 61.35 | 1.06 | NO | 1 | 8 | 35 |
| JNJ | NYSE:JNJ | Johnson & Johnson | 401.11 | 15.18 | 3.08 | YES | 1 | 8 | 35 |
| MRK | NYSE:MRK | Merck & Co., Inc. | 281.83 | 16.48 | 2.63 | NO | 1 | 8 | 35 |
| ABBV | NYSE:ABBV | AbbVie Inc | 242.70 | 10.51 | 4.30 | YES | 1 | 8 | 35 |
| PFE | NYSE:PFE | Pfizer Inc. | 212.26 | 6.07 | 4.36 | NO | 1 | 8 | 35 |
| BMY | NYSE:BMY | Bristol Myers Squibb Co. | 134.08 | 8.19 | 3.57 | NO | 1 | 8 | 35 |
| AMGN | NASDAQ:AMGN | Amgen Inc. | 115.91 | 12.45 | 3.93 | NO | 1 | 8 | 35 |
| GILD | NASDAQ:GILD | Gilead Sciences Inc. | 96.16 | 11.82 | 3.89 | NO | 1 | 8 | 35 |
| DHT.UN | TSE:DHT.UN | DIR Healthcare Trust | 0.37 | 0.00 | 4.14 | NO | 1 | 8 | 35 |
Top Picks by Bay Street Experts
Expert stock analysts have shared their opinions, and sometimes prediction, on the company.
For more top picks from stock analysts on Bay Street, check the full list of top picks by expect stock analysts from investment and asset management firms.
Not all analysts are equal and they don't cover the same type of stocks. The analysts performance and ownership is tracked for comparison.
AbbVie Inc - FAQ
What is the stock ticker for AbbVie Inc?
The stock ticker for AbbVie Inc is NYSE:ABBV.
Is AbbVie Inc a good stock to buy?
You need to consider your investment strategy and how NYSE:ABBV can fit in your portfolio.
The current dividend income score of 5/10 and dividend growth score of 5/10. Those 2 metrics together should help you decide the fit for your portfolio. Be it for income or for growth.
Is AbbVie Inc a Buy, Sell or Hold?
The Dividend Snapshot Opportunity Score of 57 out of 100.
The score reflects the strength of a buy signal but it does not show a sell signal if it's low. The higher the better.
A sell signal is more difficult as it often relies on the reason you bought the stock in the first place.
How can I buy stocks for AbbVie Inc?
You can easily buy the ABBV stock with an online trading platform.
Just make sure the stock fits your risk profile and investment goals.